阅读说明：本技术 用于癌症免疫疗法的联合激活和扩增的自然杀伤细胞的抗cxcr4抗体 (anti-CXCR4 antibodies for use in the combined activation and expansion of natural killer cells for cancer immunotherapy ) 是由 M·维拉昆卡 P·冈萨雷斯纳瓦罗 J·瓦伦丁基罗加 A·埃斯库德罗洛佩兹 L·费尔南德斯卡萨 于 2019-03-13 设计创作，主要内容包括：本公开内容提供了一种用于治疗罹患癌症的受试者的方法,包括将治疗有效量的分离的自然杀伤(NK)细胞(优选激活的和扩增的NK(NKAE)细胞)群和特异性结合癌细胞的表面上表达的C-X-C趋化因子受体4(CXCR4)的抗体或其抗原结合部分的组合施用于受试者。(The present disclosure provides a method for treating a subject afflicted with cancer comprising administering to the subject a therapeutically effective amount of a combination of an isolated population of Natural Killer (NK) cells, preferably activated and expanded NK (nkae) cells, and an antibody, or antigen-binding portion thereof, that specifically binds C-X-C chemokine receptor 4(CXCR4) expressed on the surface of cancer cells.)